“In Silico Design and Validation of CRISPR-Cas13a System As a Potential Antiviral for SARS-CoV-2 in Indonesia”. Nusantara Science and Technology Proceedings, Mar. 2022, pp. 44-51, https://doi.org/10.11594/nstp.2022.2107.